Decisive evidence that increased adipose tissue lipolysis contributes to nicotine plus HFD-induced hepatic steatosis derives from studies showing that acipimox, an inhibitor of adipose tissue lipolysis, treatment significantly prevented nicotine plus HFD-induced increase in hepatic TG levels and hepatic steatosis (Figure 2) (42)
Its a driving song
Oreskes, Naomi, and Erik M
PMID 16223098
Exacerbation of Existing Conditions: For individuals with hepatitis B or C, smoking accelerates liver damage, increasing the risk of cirrhosis and liver cancer
Multiple mechanisms have proposed to explain the accumulation of TG in the liver, including (i) increased dietary fat intake, (ii) excess free fatty acid (FFA) delivery from lipolysis of white adipose tissue, (iii) increased de novo lipogenesis, (iv) reduced fatty acid -oxidation, and (v) reduced fat export in the form of very low-density lipoprotein (VLDL) ( de novo fatty acid and cholesterol synthesis ( Two-Hit or Multiple-Hit Hypothesis Steatosis can prime the liver to develop more progressive liver pathologies in response to additional metabolic and/or environmental stressors
